
The study analyzed changes in the diagnosis and treatment of prostate cancer (PCa) over a decade (2011-2020) using data from a clinical-quality cancer registry. The results showed a significant decrease in the proportion of low-grade PCa (GG 1) diagnoses, particularly in younger men. There was also decreased interventional management for GG 1 disease, with low percentages of prostatectomies and primary radiation therapy. These findings reflect the implementation of changes in diagnostic and treatment guidelines and inform future treatment methods for PCa.
Like
Save
Share